早期输尿管癌保肾手术的临床疗效分析(附15例报告)

王小波; 李健; 冯起庆; 李昭夷

早期输尿管癌保肾手术的临床疗效分析(附15例报告)

- 天津市人民医院泌尿外科(天津, 300121)

详细信息

通讯作者: 李健,E-mail:Lijian_umc@sina.com

中图分类号: R737.13

收稿日期: 2012-12-14

Clinical analysis of nephron-sparing surgery with early carcinoma of ureter (Report of 15 cases)

- Department of Urology, Tianjin People's Hospital, Tianjin, 300121, China

More Information

Corresponding author: LI Jian, E-mail: Lijian_umc@sina.com

Received Date: 14 December 2012

摘要

摘要: 目的：探讨早期输尿管癌保留肾脏手术的可行性及疗效。方法：回顾性分析2004年6月~2010年8月15例早期输尿管癌保肾手术患者的临床资料，9例行输尿管节段切除端端吻合术；6例行输尿管末端及膀胱袖口状切除，输尿管膀胱再植术。术后均行膀胱灌注化疗。结果：本组15例患者术后病理均为移行细胞癌。14例获得随访6个月~5年，所有患者同侧输尿管及肾盂均未见复发，2例术后分别于9个月及3年出现膀胱移行细胞癌，术后膀胱癌发生率为14.3% （2/14）。结论：输尿管癌为少见尿路上皮肿瘤，保肾手术有复发的风险。但对早期、低级别输尿管癌，保肾手术效果良好。
- 输尿管癌 /
- 保肾手术 /
- 临床疗效
Abstract: Objective: To evaluate the feasibility and efficacy of partial ureteral resection for primary ureteral carcinoma.Method: From June 2004 to August 2010, 15 cases of primary ureteral carcinoma with nephron-sparing surgery were retrospectively investigated. This series included 9 cases who had undergone partial ureteral resection, and then restored the continuity of the ureter, and 6 cases who had undergone partial ureteral resection and partial cystectomy, then partial cystectomy received ureterovesical reimplantation. All cases were treated with bladder irrigation of drug after the surgery.Result: The pathological diagnosis of all cases were transitional cell carcinoma.14 cases were followed up for 6 months to 5 years. No case was found transitional cell carcinoma recurrence of ipsilateral ureter or renal pelvis. After 9 months and 3 years of transitional cell carcinoma of the bladder occurred 2 cases in 14 cases, the incidence of bladder cancer after operation is 14.3%(2/14).Conclusion: The carcinoma of ulreter is rare in urothelial tumor. The nephron-sparing surgery has the risk of recurrence,needs to undertake follow-up observation, but to early, low level of primary ureteral tumor surgery effect is good.
- carcinoma of ureter /
- nephron-sparing surgery /
- clinical efficacy

HTML全文

参考文献(10)

[1]	Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis[J]. Crit Rev Oncol Hematol, 2003, 47:155-169.
[2]	Soderdahl D W, Fabrizio M D, Rahman N U, et al. Endoscopic treatment of upper tract transitional cell carcinoma[J]. Urol Oncol, 2005, 23:114-122.
[3]	Walsh P C, Retik A B, Vaughan E D, et al. Campbell's Urology[M]. 7th ed. Beijing:Peking Science Press, 2001:2383-2394.
[4]	Marín-Aguilera M, Mengual L, Ribal M J, et al. Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma[J]. Eur Urol, 2007, 51:409-415; discussion 415.
[5]	张玉石, 李汉忠, 张锐强, 等. 伴有肾功能不全的上尿路移行细胞癌的诊断和治疗(附42例报告)[J]. 临床泌尿外科杂志, 2007, 22(9):673-675.
[6]	庄红雨, 姜永光. 输尿管镜Nd:YAG激光治疗早期输尿管癌——附5例报告[J]. 中国激光医学杂志, 2008, 17(3):179-181.
[7]	刘先东, 吴斌. 保留肾脏术式治疗输尿管肿瘤临床分析[J]. 中华实用诊断与治疗杂志, 2010, 24(2):195-197.
[8]	Ost M C, Vanderbrink B A, Lee B R, et al. Endourologic treatment of upper urinary tract transitional cell carcinoma[J]. Nat Clin Pract Urol, 2005, 2:376-383.
[9]	刘建业, 秦自科, 韩辉, 等. 输尿管部分切除术治疗原发性输尿管癌临床疗效分析(附14例报告)[J]. 临床泌尿外科杂志, 2011, 26(10):750-751.
[10]	Wright J L, Hotaling J, Porter M P. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer:a population based analysis[J]. J Urol, 2009, 181:1035-1039.